𝔖 Bobbio Scriptorium
✦   LIBER   ✦

152. Concomitant chemo-radiotherapy in patients with advanced, pimary unrespectable head and neck cancers preliminary results of phase II study

✍ Scribed by W. Sąsiadek; T. Rutkowski; A. Wygoda; M. Syguła; B. Pilecki; A. Mucha-Małecka; M. Goleń; W. Przeorek; K. Składowski

Publisher
Wielkopolskie Centrum Onkologii
Year
2003
Tongue
Polish
Weight
208 KB
Volume
8
Category
Article
ISSN
1507-1367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of piritrexim in patien
A phase II study of piritrexim in patients with advanced squamous head and neck cancer
✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

Randomized phase 2 study of concomitant
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer
✍ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##